Clinical Trial Update: beCLomethasone Efficacy in Acute Rhinosinusitis - CLEAR Study [Phase 3]

View source ↗

Summary

Phase 3 CLEAR study evaluating beclomethasone for acute rhinosinusitis has completed, reporting efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• Beclomethasone (beclomethasone)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Acute Rhinosinusitis | Phase 3 | Status: COMPLETED